Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar
December 04, 2023 07:09 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Adamas One Joins Webull’s Corporate Connect Service
November 07, 2023 09:00 ET
|
Adamas One Corp.
SCOTTSDALE, Ariz., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that...
Webull Launches in the United Kingdom
July 12, 2023 03:00 ET
|
Webull Corporation
LONDON, July 12, 2023 (GLOBE NEWSWIRE) -- Webull Corporation (“Webull”), the owner of the popular Webull trading platform, today announced the launch of its retail brokerage services in the UK....
Alarum Joins Webull Corporate Connect Service Platform
June 16, 2023 08:30 ET
|
Alarum Technologies Ltd.
TEL AVIV, Israel, June 16, 2023 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of enterprise and consumers internet access...
Silo Pharma Announces Participation on Webull Corporate Communications Service Platform
June 02, 2023 08:50 ET
|
Silo Pharma, Inc.
Webull’s investor community can now access the SILO profile for real-time data and investor communications ENGLEWOOD CLIFFS, NJ, June 02, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq:...
Tiziana Life Sciences Announces Participation on the Webull Corporate Communications Service Platform
May 23, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
OKYO Pharma Now Participating on the Webull Corporate Communications Service Platform
May 11, 2023 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye...